[Immunotherapy with hyperthermia for advanced or recurrent breast cancer patients in whom standard therapy showed no effect or was refused]
/in Breast Cancer, Hyperthermia, International Publications /von 2012-11-01 / Gan To Kagaku Ryoho 2012 Nov;39(12):1766-9Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2012-11-01 / Clin. Exp. Immunol. 2012 Nov;170(2):167-77Heat shock proteins (HSPs) based anti-cancer vaccines
/in Hyperthermia, International Publications /von 2012-11-01 / Curr. Mol. Med. 2012 Nov;12(9):1183-97Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2012-11-01 / J. Cell. Mol. Med. 2012 Nov;16(11):2827-37Targeting cancer stem cells via dendritic-cell vaccination
/in Dendritic Cells, International Publications /von 2012-11-01 / Oncoimmunology 2012 Nov;1(8):1401-1403
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution